Table 1.
Epidemiological features of the 89 cohort members between the three collection periods
| Mar–May 2020 (n = 27) | Sep–Nov 2020 (n = 43) | Jan–Feb 2021 (n = 19) | |
|---|---|---|---|
| Age (years) | |||
| 0–20 | 3 (11%) | 3 (7%) | 5 (26%) |
| 21–40 | 4 (15%) | 8 (19%) | 1 (5%) |
| 41–60 | 4 (15%) | 15 (35%) | – |
| 61–80 | 10 (37%) | 13 (30%) | 6 (32%) |
| >80 | 3 (11%) | 4 (9%) | 7 (37%) |
| Unknown | 3 (11%) | – | |
| Gender | |||
| Male (%) | 16 (59%) | 27 (63%) | 5 (26%) |
| Female (%) | 8 (30%) | 16 (37%) | 14 (74%) |
| Unknown | 3 (11%) | – | – |
| Disease severity (%) | |||
| Asymptomatic | 11 (41%) | 15 (35%) | – |
| Mild | 7 (26%) | 6 (14%) | – |
| Moderate | 2 (7%) | – | 4 (21%) |
| Severe | 5 (2 dead) (19%) | 4 (1 dead) (9%) | 1 (5%) |
| Unknown | 2 (7%) | 18 (42%) | 14 (74%) |
Note: The values shown in this table are expressed in the format of number (percentage).